I am not sure how you came to your conclusion “you think

New Post Public Reply Private Reply Replies (1) Message Board
Mo sox0407 #49891
489
I am not sure how you came to your conclusion “you think the MFO will convert all $10M into Class A shares at once” from my statements below:
“In a worse-case scenario where IPIX would need to tap into the entire $10M let’s say this MFO ends up paying .15/share when all is said and done after converting warrants into common shares. A key part of this deal is that there are limits on how much and when shares can be sold to insure that shares are not flooded on the market.”

“If the Term Sheet deal does get finalized this quarter than most of the $10M will not be needed and the total outstanding shares will be less than 200M which would equate to an even higher share price than the above example.

As far as your following statements and attachments, can you understand why many longs on this board believe this was FUD or at a very minimum soft bashing?

“Preferred convertible is called death spiral for a reason.”
“Before the MFO decides to convert all the shares into Class A, they are our enemy.”
And from your attachment:
What is a 'Death Spiral'
Death spiral is a term applied to a type of convertible debt that stimulates an ever-increasing number of shares, leading to steep stock price drops. The convertible bond, unlike a conventional convertible one, converts into a fixed value instead of a fixed number of shares. If this bond is converted into stock, the price of the stock tends to drop due to the increased supply of shares. This, in turn, encourages more conversion because the convertible debt owners can obtain — and then sell — even more shares of the stock with the fixed value feature. Theoretically, the death spiral can end with the stock at or near a zero dollar value.

A couple of weeks ago you re-posted a ihub post of a conversation between PlentyParanoid (scottsmith) and justfactsmam (loanranger) and I posted that as a long you should be more careful to not repeat FUD from 2 of the most well-known bashers. You never responded. You posted the VC article and Drano pointed out to you that it had zero validity in biotech license deals. You reposted the same article.
I have always respected you as one of the high value posters with you posts on IPIX science and competitive marketplace but your recent posts have been disappointing. I too have been invested in IPIX since 2011 and I have a sizable position with an average cost basis of over $1. I am as pissed off as anyone that IPIX is sitting at 20 cents but you can simply go over to the other board that you moderate at and it is obvious that a vast majority of posters on that site are full time bashers. Why would someone spend years continually bashing IPIX management and science unless they have a financial interest in seeing it fail? Sox, you are good at crunching numbers so what is your take on what a license deal with 2 indications of B will look like? If the Term Sheet deal happens in the next 10 months will this MFO deal really have any major significance? Why are you and others spending so much energy on the MFO deal vs focusing on where IPIX will likely be in the near future?

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 5

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 8

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 3

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 6

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 6

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 7

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 4

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 7

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading

Top 5 Most Recently Viewed Articles

Urbo Bankas Reports Strong Growth and Strategic Initiatives

Updated Category News Views 122

Urbo Bankas' Financial Performance Analysis Urbo Bankas UAB has demonstrated remarkable resilience and growth over the recent quarters. Based in Lithuania and recognized for their innovative banking solutions, the bank has reported impressive increases in both its loan and deposit portfolios, marking a significant achievement for the institution. Growth in Loans and...

Continue Reading
Latest Update on Signify's Share Buyback Program

Updated Category News Views 198

Signify's Share Repurchase Program Overview Signify (Euronext: LIGHT), recognized as the global leader in lighting solutions, has recently provided an important update on its share repurchase program. This initiative is key to the company’s commitment to returning value to its shareholders while strategically managing its equity. Recently, from May 19 to May 23, 2025,...

Continue Reading
ConnectOne Bancorp's Q3 Earnings: Merger Insights and Outlook

Updated Category News Views 215

ConnectOne Bancorp's Strategic Endeavors in the Third Quarter In a recent earnings call, ConnectOne Bancorp (NASDAQ: CNOB) revealed a merger with First of Long Island Corporation, aimed at significantly boosting the bank's market footprint and credit quality. This merger, anticipated to finalize in the first half of 2025, positions ConnectOne with assets exceeding $14...

Continue Reading
Creator Economy to Hit $1.34 Trillion by 2033

Updated Category News Views 4

From Trend to Digital Powerhouse Who’d have thought that a bunch of folks making videos in their bedrooms could morph into a billion-dollar market juggernaut? Yet, that's exactly what's happening with the creator economy. As it stands, this beast of a market is chomping through revenue like a hungry wolf in a sheep pen, soaring from a cool $252.33 billion in 2025 to an...

Continue Reading
Celebrating Rx Relief's Commitment to Women's Empowerment

Updated Category News Views 120

Rx Relief Receives Notable Recognition for Women's Empowerment In a remarkable achievement, Rx relief has been honored as one of the Best Staffing Firms for Women by ClearlyRated. This recognition highlights their commitment to fostering an inclusive and empowering environment for women within the organization. Such accolades serve as a testament to the dedication Rx...

Continue Reading